GlassScriptPhysician profile
Lisa Wallenfels
NPI 1891839064
$6,059.03
in general payments reported to CMS, 2019-2025
33 companies · $819 in 2025
The $819 reported for 2025 was more than what 94% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $892 · 2022: $1,403 · 2023: $1,561 · 2024: $1,385 · 2025: $819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,666 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,665.90 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $1,099.46 | 2021-2025 | |
| Astellas Pharma US INC | $480.49 | 2022-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $384.28 | 2021-2025 | Slynd |
| Abbvie INC. | $342.98 | 2021-2023 | |
| Agile Therapeutics, INC. | $322.62 | 2021-2024 | Twirla |
| Therapeuticsmd, INC. | $306.57 | 2021-2022 | |
| Amgen INC. | $268.29 | 2021-2025 | Prolia, Evenity, Prolia |
| Pfizer INC. | $250.54 | 2021-2025 | |
| Myovant Sciences INC. | $230.75 | 2021-2022 | |
| Daiichi Sankyo INC. | $229.33 | 2021-2024 | Injectafer |
| Coopersurgical, INC. | $203.20 | 2021-2025 | Paragard T 380a, Paragard T 380a |
| Biogen, INC. | $199.15 | 2023-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $192.54 | 2023-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $166.02 | 2021-2025 | |
| Mylan Pharmaceuticals INC. | $159.12 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $142.82 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $141.02 | 2021-2024 | Gardasil 9, Gardasil |
| Evofem Biosciences, INC. | $115.37 | 2021-2024 | Phexxi |
| Millicent US INC | $101.37 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Organon LLC | $99.38 | 2021-2025 | Nexplanon |
| Medtronic, INC. | $79.22 | 2024-2025 | Truclear |
| Avion Pharmaceuticals | $71.40 | 2021 | |
| Shield Therapeutics INC | $68.04 | 2023 | Accrufer |
| Gilead Sciences, INC. | $64.82 | 2022-2023 | |
| Scynexis, INC. | $53.91 | 2022 | |
| Lilly USA, LLC | $51.97 | 2021-2025 | Zepbound |
| Roche Diagnostics Corporation | $50.51 | 2021 | |
| Novo Nordisk INC | $47.98 | 2023-2025 | Wegovy |
| Hologic Sales and Service, LLC | $47.90 | 2024 | Aptima |
| Axsome Therapeutics, INC. | $31.37 | 2023 | Auvelity |
| Dexcom, INC. | $27.52 | 2025 | Dexcom G6 Transmitter |
| Smith+Nephew, INC. | $14.76 | 2022 | |
| Cepheid | $14.33 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Wallenfels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.